Kymera Therapeutics Appoints Felix J. Baker, Ph.D., as Chairman of the Board of Directors
Summary
Kymera Therapeutics named Felix J. Baker as Chairman of its Board of Directors. Bruce Booth will step down as chairman but stay on as an independent director. The company says Baker has already been an active strategic partner and will help guide the next phase of growth. This change comes as Kymera advances multiple mid- to late-stage programs and expands its oral degrader pipeline.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected